Antimicrobial Agents — MCQs

Antimicrobial Agents Indian Medical PG Practice Questions and MCQs

Question 71: Which drug is used in the treatment of hepatitis B infection?

A. Entecavir (Correct Answer)
B. Astacavir
C. Zanamivir
D. Abacavir

Explanation: **Explanation:** **Entecavir (Option A)** is a potent deoxyguanosine nucleoside analog that inhibits Hepatitis B Virus (HBV) polymerase. It acts at three stages of viral replication: priming of HBV DNA polymerase, reverse transcription of the negative-strand DNA, and synthesis of the positive-strand DNA. It is considered a first-line treatment for chronic Hepatitis B due to its high potency and a very high genetic barrier to resistance. **Analysis of Incorrect Options:** * **Astacavir (Option B):** This is a distractor; no such FDA-approved antiviral drug exists. It is likely a phonetic confusion with Abacavir or Atazanavir. * **Zanamivir (Option C):** This is a neuraminidase inhibitor used for the treatment and prophylaxis of **Influenza A and B**. It is typically administered via inhalation. * **Abacavir (Option D):** This is a Nucleoside Reverse Transcriptase Inhibitor (NRTI) used exclusively in the treatment of **HIV-1 infection**. It is notorious for causing hypersensitivity reactions in patients with the HLA-B*5701 allele. **High-Yield Clinical Pearls for NEET-PG:** * **First-line HBV Drugs:** Entecavir and Tenofovir (TDF or TAF) are the preferred oral agents. * **Lamivudine:** Though used for HBV, it is no longer first-line due to high rates of resistance (M204V mutation). * **Adefovir:** Less commonly used now due to nephrotoxicity. * **Interferon-alpha:** Used in selected HBV cases but contraindicated in decompensated liver disease. * **Co-infection:** If a patient has both HIV and HBV, Tenofovir + Lamivudine/Emtricitabine should be part of the ART regimen to treat both viruses simultaneously.

Question 72: All of the following are used in the treatment of Pneumocystis jirovecii pneumonia except?

A. Pentamidine
B. Dapsone
C. Cotrimoxazole
D. Fluoroquinolones (Correct Answer)

Explanation: **Explanation:** *Pneumocystis jirovecii* is a unique unicellular fungus that causes opportunistic pneumonia (PCP), primarily in immunocompromised patients (e.g., HIV/AIDS). Unlike most fungi, it lacks ergosterol in its cell membrane, making it resistant to standard antifungals like Amphotericin B or Azoles. **Why Fluoroquinolones are the Correct Answer:** Fluoroquinolones (e.g., Ciprofloxacin, Levofloxacin) act by inhibiting DNA gyrase and Topoisomerase IV in bacteria [1]. They have **no clinical activity** against *P. jirovecii*. Therefore, they are not used in the treatment or prophylaxis of PCP. **Analysis of Other Options:** * **Cotrimoxazole (Trimethoprim-Sulfamethoxazole):** This is the **drug of choice** for both treatment and prophylaxis of PCP [1, 5]. It works by inhibiting sequential steps in the folate synthesis pathway. * **Pentamidine:** An alternative agent used in patients who cannot tolerate Cotrimoxazole or in severe cases [2]. It is administered intravenously or via inhalation (though inhalation is less effective for treatment) [2]. * **Dapsone:** Often used in combination with Trimethoprim, it is an effective alternative for prophylaxis and mild-to-moderate treatment in patients with sulfonamide allergies. **High-Yield Clinical Pearls for NEET-PG:** 1. **First-line Treatment:** Cotrimoxazole (High dose: 15–20 mg/kg/day of TMP component) [3]. 2. **Steroid Indication:** In HIV patients, if $PaO_2 < 70$ mmHg or A-a gradient $> 35$ mmHg, add corticosteroids to prevent clinical worsening due to inflammation from dying organisms [3]. 3. **Other Alternatives:** Atovaquone (mild cases) and Clindamycin + Primaquine (moderate-to-severe cases). 4. **Prophylaxis:** Indicated in HIV patients when CD4 count falls below **200 cells/µL**.

Question 73: A 15-year-old boy presents with a two-day history of fever, altered sensorium, and a purpuric rash. On examination, he is stuporous, with a BP of 90/60 mmHg and extensive palpable purpura on his legs. Which of the following would be the most appropriate initial choice of antibiotic?

A. Vancomycin
B. Penicillin G (Correct Answer)
C. Ciprofloxacin
D. Gentamicin

Explanation: ### Explanation The clinical presentation of fever, altered sensorium, and a characteristic **purpuric rash** (especially palpable purpura) in a young patient is highly suggestive of **Meningococcemia** (caused by *Neisseria meningitidis*). This is a medical emergency that can rapidly progress to Waterhouse-Friderichsen syndrome and septic shock. **1. Why Penicillin G is the Correct Answer:** Historically and for exam purposes, **Penicillin G** remains the drug of choice for confirmed meningococcal infections. While third-generation cephalosporins (like Ceftriaxone) are often used empirically in clinical practice to cover both *S. pneumoniae* and *N. meningitidis*, Penicillin G is the classic, highly effective treatment for susceptible strains of *N. meningitidis*. It has excellent bactericidal activity and achieves therapeutic concentrations in the CSF when the meninges are inflamed. **2. Why the Other Options are Incorrect:** * **Vancomycin (A):** Primarily used for MRSA or resistant *S. pneumoniae*. It does not provide adequate coverage for Gram-negative diplococci like *N. meningitidis*. * **Ciprofloxacin (C):** While used for **prophylaxis** in close contacts of a patient with meningococcal meningitis, it is not the first-line agent for the treatment of the acute disease. * **Gentamicin (D):** An aminoglycoside used for Gram-negative enteric bacilli. It has poor CSF penetration and is ineffective against *N. meningitidis*. **3. NEET-PG High-Yield Pearls:** * **Drug of Choice (DOC) for Meningococcemia:** Penicillin G. * **DOC for Meningococcal Prophylaxis:** Rifampicin (most common), Ciprofloxacin, or Ceftriaxone. * **Classic Triad:** Fever, neck stiffness, and altered mental status (though the purpuric rash is the "giveaway" for Meningococcemia). * **Mechanism of Penicillin:** Inhibits bacterial cell wall synthesis by binding to Penicillin-Binding Proteins (PBPs) and inhibiting transpeptidation.

Question 74: Which of the following drugs is NOT effective in cases of Pneumocystis jirovecii pneumonia?

A. Pentamidine
B. Trimethoprim-dapsone
C. Clindamycin plus primaquine
D. Cefepime (Correct Answer)

Explanation: **Explanation:** *Pneumocystis jirovecii* is a unique unicellular fungus (formerly classified as a protozoan) that causes opportunistic pneumonia (PJP), primarily in immunocompromised patients such as those with HIV/AIDS. **Why Cefepime is the Correct Answer:** Cefepime is a **fourth-generation cephalosporin** antibiotic. Its mechanism of action involves inhibiting bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs). Since *Pneumocystis jirovecii* is a fungus and lacks a bacterial peptidoglycan cell wall, beta-lactam antibiotics like Cefepime have **no activity** against it. Cefepime is typically reserved for serious bacterial infections, including *Pseudomonas aeruginosa*. **Analysis of Other Options:** * **Pentamidine (Option A):** An aromatic diamidine used as an alternative for moderate-to-severe PJP in patients who cannot tolerate Co-trimoxazole. It can be administered intravenously or via aerosolized form. * **Trimethoprim-dapsone (Option B):** This combination is an effective oral regimen for mild-to-moderate PJP. Dapsone acts as a sulfonamide-like folate synthesis inhibitor. * **Clindamycin plus primaquine (Option C):** This is a standard alternative regimen for mild-to-severe PJP, especially in patients with sulfa allergies. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Co-trimoxazole (Trimethoprim-Sulfamethoxazole) is the DOC for both prophylaxis and treatment of PJP. * **Prophylaxis Criteria:** In HIV patients, PJP prophylaxis is started when the **CD4 count falls below 200 cells/mm³**. * **Adjunctive Therapy:** Corticosteroids are added to the treatment regimen if the patient is hypoxic (PaO₂ < 70 mmHg or A-a gradient > 35 mmHg) to reduce inflammation caused by dying organisms. * **Diagnosis:** Silver stain (Gomori Methenamine Silver) showing "crushed ping-pong ball" appearance of cysts.

Question 75: Which one of the following is a mechanism underlying the resistance of strains of S. pneumoniae to the widely used antibiotic, ciprofloxacin?

A. Reduced topoisomerase sensitivity to inhibitors (Correct Answer)
B. Increased synthesis of PABA
C. Formation of methyltransferases that change receptor structure
D. Structural changes in porins

Explanation: **Explanation:** **Ciprofloxacin** is a second-generation fluoroquinolone that acts by inhibiting bacterial **DNA gyrase (Topoisomerase II)** and **Topoisomerase IV**. These enzymes are essential for DNA replication, transcription, and repair. **1. Why Option A is Correct:** The primary mechanism of resistance in *Streptococcus pneumoniae* against fluoroquinolones is **chromosomal mutations** in the "Quinolone Resistance-Determining Regions" (QRDR) of the genes encoding Topoisomerase IV (*parC*) and DNA gyrase (*gyrA*). These mutations lead to **reduced target sensitivity**, meaning the drug can no longer effectively bind to the enzyme-DNA complex. An additional mechanism often seen in *S. pneumoniae* is the active efflux of the drug via membrane transporters (e.g., PatA/B pumps). **2. Analysis of Incorrect Options:** * **Option B (Increased synthesis of PABA):** This is a mechanism of resistance against **Sulfonamides**. By overproducing PABA, bacteria outcompete the drug for the enzyme dihydropteroate synthase. * **Option C (Methyltransferases):** This mechanism involves the methylation of the 23S rRNA, which prevents drugs like **Macrolides (Erythromycin)**, Lincosamides, and Streptogramins (MLS_B resistance) from binding to the 50S ribosomal subunit. * **Option D (Structural changes in porins):** While common in Gram-negative bacteria (like *Pseudomonas*), *S. pneumoniae* is a Gram-positive organism and lacks an outer membrane with porins. **High-Yield Clinical Pearls for NEET-PG:** * **Respiratory Quinolones:** Levofloxacin, Moxifloxacin, and Gemifloxacin are preferred over Ciprofloxacin for *S. pneumoniae* because they have enhanced activity against Gram-positive cocci. * **Dual Target:** Fluoroquinolones are unique because they target two different enzymes; resistance usually requires mutations in both targets to be clinically significant. * **Side Effects:** Watch for tendon rupture (Achilles), QT prolongation, and dysglycemia in elderly patients.

Question 76: Amphotericin B treatment mandates the monitoring of which of the following electrolytes?

A. Sodium (Na+)
B. Calcium (Ca2+)
C. Magnesium (Mg2+) (Correct Answer)
D. None of the above

Explanation: **Explanation:** Amphotericin B is a potent antifungal agent known for its significant renal toxicity, often referred to as "Amphoterrible" due to its side effect profile. The drug causes nephrotoxicity through two mechanisms: direct toxicity to the renal tubular epithelium and pre-renal vasoconstriction. **Why Magnesium (Mg²⁺) is the correct answer:** Amphotericin B increases the permeability of the distal tubule and collecting duct. This leads to a "leak" of intracellular electrolytes into the tubular lumen, resulting in significant renal wasting of **Magnesium** (Hypomagnesemia) and **Potassium** (Hypokalemia). Monitoring and replacement of these electrolytes are mandatory during therapy to prevent cardiac arrhythmias and neuromuscular complications. **Analysis of Incorrect Options:** * **A. Sodium (Na⁺):** While Amphotericin B affects the kidneys, it does not typically cause significant clinical fluctuations in sodium levels that require the same level of intensive monitoring as magnesium or potassium. In fact, "saline loading" (giving normal saline) is actually used as a protective measure to reduce Amphotericin-induced nephrotoxicity. * **B. Calcium (Ca²⁺):** Although magnesium deficiency can secondary lead to hypocalcemia, calcium is not the primary electrolyte directly wasted by the renal tubules due to Amphotericin B. **High-Yield Clinical Pearls for NEET-PG:** * **Most common side effect:** Infusion-related reactions (fever, chills/rigors—"shake and bake" phenomenon). * **Most serious/dose-limiting side effect:** Nephrotoxicity (Azotemia). * **Electrolyte triad:** Hypomagnesemia, Hypokalemia, and Renal Tubular Acidosis (Type 1). * **Prevention:** Use of **Liposomal Amphotericin B** (decreases nephrotoxicity) and **Saline loading** before infusion.

Question 77: Which drug is safely given in pregnancy?

A. Antifolate
B. Quinine
C. Chloroquine (Correct Answer)
D. Primaquine

Explanation: **Explanation:** **Chloroquine** is the drug of choice for the treatment and prophylaxis of malaria in pregnancy. It is considered safe as it does not have documented teratogenic effects at standard therapeutic doses. According to WHO and national guidelines, it can be used across all trimesters for sensitive *P. falciparum* and *P. vivax* infections. **Analysis of Incorrect Options:** * **Antifolates (e.g., Methotrexate, Pyrimethamine):** These interfere with folic acid synthesis/metabolism. Folate is crucial for neural tube development; hence, antifolates are highly teratogenic, especially in the first trimester. * **Quinine:** While used in severe malaria or chloroquine-resistant cases during pregnancy, it is not the "safest" first-line choice. In high doses, it is associated with hyperinsulinemia (causing maternal hypoglycemia) and potential oxytocic effects (risk of abortion/preterm labor). * **Primaquine:** This is strictly **contraindicated** in pregnancy. It can cross the placenta and cause severe hemolysis in the fetus, who is naturally deficient in G6PD enzyme. **NEET-PG High-Yield Pearls:** * **Malaria in Pregnancy:** For Chloroquine-resistant *P. falciparum*, the current recommendation is **Artesunate + Clindamycin** (1st trimester) and **ACT** (2nd and 3rd trimesters). * **Primaquine Rule:** Always test for G6PD deficiency before administration. In pregnancy, radical cure for *P. vivax* (using Primaquine) is deferred until after delivery. * **Safe Antibiotics in Pregnancy (Mnemonic: CAMP):** **C**ephalosporins, **A**moxicillin/Ampicillin, **M**acrolides (Erythromycin/Azithromycin), **P**enicillins.

Question 78: Which one of the following drugs is most likely to be associated with elevations of pancreatic enzymes, including amylase and lipase?

A. Erythromycin
B. Didanosine (Correct Answer)
C. Isoniazid
D. Azidothymidine

Explanation: **Explanation:** **Didanosine (ddI)**, a Nucleoside Reverse Transcriptase Inhibitor (NRTI) used in HIV treatment, is classically associated with **acute pancreatitis** [1], [4]. The mechanism involves mitochondrial toxicity due to the inhibition of mitochondrial DNA polymerase-gamma [2], [4]. This leads to pancreatic acinar cell dysfunction, manifesting clinically as abdominal pain and significant elevations in serum **amylase and lipase** [1]. **Analysis of Options:** * **Didanosine (Correct):** Pancreatitis is its most serious dose-limiting toxicity (occurring in up to 7% of patients) [1], [3]. Risk is higher in patients with alcoholism, hypertriglyceridemia, or those co-administered with Stavudine. * **Erythromycin:** Primarily associated with GI upset (motilin receptor agonism) and **cholestatic hepatitis** (especially the estolate form), but not pancreatitis. * **Isoniazid (INH):** The hallmark side effect is **hepatotoxicity** and peripheral neuropathy (due to Vitamin B6 deficiency). While rare cases of INH-induced pancreatitis exist, it is not a classic or high-yield association compared to Didanosine. * **Azidothymidine (Zidovudine/AZT):** The major dose-limiting toxicities are **bone marrow suppression** (anemia, neutropenia) and myopathy. **NEET-PG High-Yield Pearls:** * **NRTI Class Side Effects:** Lactic acidosis and hepatic steatosis (due to mitochondrial toxicity) [2]. * **Specific NRTI Associations:** * **Didanosine/Stavudine:** Pancreatitis and Peripheral Neuropathy [4]. * **Zidovudine:** Anemia (Macrocytic). * **Abacavir:** Hypersensitivity reaction (linked to **HLA-B*5701**). * **Tenofovir:** Renal toxicity (Fanconi syndrome). * **Other Drugs causing Pancreatitis:** Valproate, Azathioprine, Sulfonamides, and Thiazides (Mnemonic: **"FAT SHEEP"** - Furosemide, Azathioprine, Thiazides, Sulfonamides, HCTZ, Estrogen, Enalapril, Pentamidine/Pentasa).

Question 79: Which of the following is the drug of choice for CMV retinitis?

A. Acyclovir
B. Tenofovir
C. Ganciclovir (Correct Answer)
D. Abacavir

Explanation: ### Explanation **Correct Option: C. Ganciclovir** Ganciclovir is the **drug of choice (DOC)** for Cytomegalovirus (CMV) infections, particularly CMV retinitis in immunocompromised patients (e.g., those with HIV/AIDS). * **Mechanism:** It is a nucleoside analogue that requires triphosphorylation to become active. The first phosphorylation is catalyzed by a **CMV-specific protein kinase (UL97)**. Once active, it competitively inhibits viral DNA polymerase, terminating viral DNA synthesis. * **Alternative:** Valganciclovir (the oral prodrug) is often used for maintenance therapy due to better oral bioavailability. **Analysis of Incorrect Options:** * **A. Acyclovir:** While it is a nucleoside analogue, it is primarily effective against HSV-1, HSV-2, and VZV. It has **minimal activity against CMV** because CMV lacks the specific thymidine kinase required to activate acyclovir efficiently. * **B. Tenofovir:** This is a Nucleotide Reverse Transcriptase Inhibitor (NRTI) used in the treatment of **HIV and Hepatitis B (HBV)**. It does not have clinical activity against the herpesvirus family. * **C. Abacavir:** This is an NRTI used exclusively for **HIV treatment**. It is notably associated with a hypersensitivity reaction linked to the HLA-B*5701 allele. **High-Yield Clinical Pearls for NEET-PG:** 1. **Dose-limiting toxicity of Ganciclovir:** Bone marrow suppression (specifically **Neutropenia**). 2. **Foscarnet:** Used as a second-line agent for ganciclovir-resistant CMV; its main side effect is **nephrotoxicity** and electrolyte imbalances. 3. **Cidofovir:** Another alternative for CMV retinitis; must be co-administered with **Probenecid** to reduce nephrotoxicity. 4. **Letermovir:** A newer drug that inhibits the CMV DNA terminase complex, used for prophylaxis in hematopoietic stem cell transplant recipients.

Question 80: All of the following statements about penicillin G are true EXCEPT:

A. It is actively secreted in tubules
B. It is never administered orally (Correct Answer)
C. It is effective against gram-positive as well as some gram-negative bacteria
D. It acts by inhibiting cell wall synthesis

Explanation: ### Explanation **Why Option B is the Correct Answer (The "Except" Statement):** Penicillin G (Benzylpenicillin) is **acid-labile**, meaning it is rapidly destroyed by gastric acid in the stomach. While it is primarily administered parenterally (IV or IM) to ensure reliable therapeutic levels, the statement that it is "never" administered orally is technically incorrect in a historical and pharmacological context. **Penicillin V (Phenoxymethylpenicillin)** is the acid-stable oral alternative; however, Penicillin G *can* be given orally, but the dose must be 5 times higher to compensate for poor absorption, making it inefficient and clinically obsolete for oral use. In the context of NEET-PG, Penicillin G is characterized by its parenteral route due to acid instability. **Analysis of Other Options:** * **Option A:** Penicillin G is rapidly excreted by the kidneys. Approximately **90% is secreted via active tubular secretion** (organic anion transporter), while only 10% is filtered by the glomerulus. This is why Probenecid is used to prolong its action by inhibiting this secretion. * **Option C:** It has a narrow but potent spectrum. It is highly effective against **Gram-positive** cocci/bacilli and specific **Gram-negative** organisms like *Neisseria meningitidis* and *Treponema pallidum* (Spirochetes). * **Option D:** Like all beta-lactams, it inhibits **bacterial cell wall synthesis** by binding to Penicillin-Binding Proteins (PBPs), thereby inhibiting the cross-linking of peptidoglycan chains (transpeptidation). **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Penicillin G remains the gold standard for **Syphilis** (all stages), Gas gangrene (*C. perfringens*), and Anthrax. * **Probenecid Interaction:** Competitively inhibits tubular secretion of penicillin, increasing its plasma half-life. * **Benzathine Penicillin:** A repository (long-acting) form given IM for rheumatic fever prophylaxis. * **Jarisch-Herxheimer Reaction:** A classic systemic reaction (fever, chills) seen after the first dose of Penicillin in Syphilis patients due to the release of endotoxins from dying spirochetes.

Practice by Chapter

Beta-Lactam Antibiotics

Practice Questions

Aminoglycosides

Practice Questions

Macrolides and Ketolides

Practice Questions

Tetracyclines

Practice Questions

Quinolones

Practice Questions

Sulfonamides and Trimethoprim

Practice Questions

Antimycobacterial Drugs

Practice Questions

Antifungal Agents

Practice Questions

Antiviral Drugs

Practice Questions

Antiparasitic Agents

Practice Questions

Principles of Antimicrobial Selection

Practice Questions

Antimicrobial Resistance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free